Think this has a run. Presentation was very informative and clearly laid out the various pipelines for them. Tapping into Asia where programs are ahead of the US and being done at a fraction of the price could give AD1 a pipeline of potential product that it can advance through to the regulatory requirements of the West. The story here is really, the USA is pricing themselves out of the market, and the bigger populations are in Asia, not the USA.
It also sounds very positive for an 214 deal to happen in the next few months
1AD Price at posting:
3.0¢ Sentiment: Buy Disclosure: Held
